Artigo de periodico

How effective is the use of glycemic variability in the follow-up of type 1 diabetes under intensive care? (2020)

• Authors:
  • Rodrigues, Ricardo
  • MEDEIROS, LUCIANA ALVES
  • Cunha, Lucas Moreira
  • Garrote-Filho,Mario da Silva
  • Bernardino Neto, Morun
  • Freita, Marcia Aires Rodrigues
  • Jorge, Paulo Tannus
  • Resende, Elmiro Santos
  • Silva, Nilson Penha
• Autor USP: BERNARDINO NETO, MORUN - EEL
• Unidade: EEL
• DOI: 10.15761/DU.1000141
• Subjects: DIABETES MELLITUS; GLICEMIA
• Keywords: Variabilidade Glicêmica; Diabete Melitus Tipo 1
• Agências de fomento:
  • Financiamento FAPEMIG
  • Financiamento CNPq
• Language: Português
• Abstract: Background: Glycemic variability (GV) has been identified as an important tool in the monitoring of type 1 diabetes mellitus (T1D), due to its ability to identify patients at greater risk of severe hypoglycemia and to constitute an independent risk factor for chronic complications of this disease. This study aimed to evaluate the GV pattern between individuals with T1D under different types of intensive treatment and the correlations of this GV with different clinical and biochemical variables. Methods: Volunteers with T1D (n = 90) under different types of intensive treatment (NPH insulin, n=54; insulin glargine, n=19; and continuous subcutaneous insulin infusion (CSII) system, n=17) were analyzed in relation to glycemic control and GV. The glycated hemoglobin (HbA1c) and estimated average glucose (eAG) were used to estimate glycemic control. The daily average glucose (DAG) and its standard deviation (SDDAG) and coefficient of variability (CVDAG), as well the change in the levels of glycated hemoglobin (ΔHbA1c) were used to estimate GV. Results: Patients under CSII presented lower values of HbA1c, eAG, DAG, SDDAG and CVDAG than the other groups. DAG (median = 189 mg/dL and IQR = 157-232) and SDDAG (median = 89.8 mg/dL and IQR = 72-111) correlated positively with HbA1c, with correlations coefficients of 0.67 and 0.64, respectively. Conclusions: The glycemic variability in patients with type 1 diabetes, even under intensive treatment, has a great amplitude, and has direct correlations with the classic parameters of disease control. DAG and SDDAG can be used in the short term as predictors of the glycated hemoglobin levels in order to allow directions and earlier adaptations in clinical management.
• Imprenta:
  • Publisher place: São Paulo
  • Date published: 2020
• Source:
  • Título: Diabetes Updates
  • ISSN: 26315483
  • Volume/Número/Paginação/Ano: v., n. , p.1-5, 2020

Informações sobre o DOI: 10.15761/DU.1000141 (Fonte: oaDOI API)
• Este periódico é de acesso aberto
• Este artigo é de acesso aberto
• URL de acesso aberto
• Cor do Acesso Aberto: gold
• Licença: cc-by

---

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  RODRIGUES, Ricardo et al. How effective is the use of glycemic variability in the follow-up of type 1 diabetes under intensive care?. Diabetes Updates, n. , p. 1-5, 2020Tradução . . Disponível em: https://doi.org/10.15761/DU.1000141. Acesso em: 08 out. 2024.

• APA

  Rodrigues, R., MEDEIROS, L. U. C. I. A. N. A. A. L. V. E. S., Cunha, L. M., Garrote-Filho, M. da S., Bernardino Neto, M., Freita, M. A. R., et al. (2020). How effective is the use of glycemic variability in the follow-up of type 1 diabetes under intensive care? Diabetes Updates, ( ), 1-5. doi:10.15761/DU.1000141

• NLM

  Rodrigues R, MEDEIROS LUCIANAALVES, Cunha LM, Garrote-Filho M da S, Bernardino Neto M, Freita MAR, Jorge PT, Resende ES, Silva NP. How effective is the use of glycemic variability in the follow-up of type 1 diabetes under intensive care? [Internet]. Diabetes Updates. 2020 ;( ): 1-5.[citado 2024 out. 08 ] Available from: https://doi.org/10.15761/DU.1000141

• Vancouver

  Rodrigues R, MEDEIROS LUCIANAALVES, Cunha LM, Garrote-Filho M da S, Bernardino Neto M, Freita MAR, Jorge PT, Resende ES, Silva NP. How effective is the use of glycemic variability in the follow-up of type 1 diabetes under intensive care? [Internet]. Diabetes Updates. 2020 ;( ): 1-5.[citado 2024 out. 08 ] Available from: https://doi.org/10.15761/DU.1000141

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Saúde Mental, Uso de Álcool e Qualidade do Sono em Estudantes de uma Universidade Pública
• Expression of epidermal growth factor receptor (EGFR) in blood and tumor in patients with breast carcinoma: Prognostic analysis.
• Aging profile, adherence to the Elderly Health Handbook and health self-perception, Ituiutaba-MG (2015 and 2018)
• Effects of acute and chronic exercise on the osmotic stability of erythrocyte membrane of competitive swimmers
• Influence of erythrocyte membrane stability in atherosclerosis
• Oropharyngeal Colostrum Administration and Anti-inflammatory Effects in Very Low Birth Weight Preterm Neonates
• Epidermal growth factor receptor (EGFR) expression in the serum of patients with triple-negative breast carcinoma: prognostic value of this biomarker
• The impact of coffee certification on production costs and price paid to the rural producers: a discussion from the viewpoint of transaction cost economics
• Decreased plasma iron levels in women with hyperglycemia are associated with inflammatory status and involve increased HbA1c, osmotic stability, and volume variability of red blood cells
• EGF (epidermal growth factor) receptor expression in blood: Prognostic biomarker in overall survival (OS) of patients with non-metastatic triple negative (TN) breast carcinoma.